Disease name:	Cervial Cancer
miRNA_name	PMID	Description	Causality
hsa-mir-508	30568508	RESULTS: According to the The Cancer Genome Atlas data, hsa-miR-508, hsa-miR2, and hsa-miR-526b expression levels were significantly lower in early-stage CESC patients with LNM than in patients without LNM. CONCLUSION: Our results indicate that hsa-miR-508, hsa-miR2, and hsa-miR-526b may be potential diagnostic biomarkers for early-stage CESC with LNM, and serve as prognostic predictors for patients with CESC.	Unknown
hsa-mir-526b	30568508	RESULTS: According to the The Cancer Genome Atlas data, hsa-miR-508, hsa-miR2, and hsa-miR-526b expression levels were significantly lower in early-stage CESC patients with LNM than in patients without LNM. CONCLUSION: Our results indicate that hsa-miR-508, hsa-miR2, and hsa-miR-526b may be potential diagnostic biomarkers for early-stage CESC with LNM, and serve as prognostic predictors for patients with CESC.	Unknown
hsa-mir-509-2	30568508	RESULTS: According to the The Cancer Genome Atlas data, hsa-miR-508, hsa-miR2, and hsa-miR-526b expression levels were significantly lower in early-stage CESC patients with LNM than in patients without LNM. CONCLUSION: Our results indicate that hsa-miR-508, hsa-miR2, and hsa-miR-526b may be potential diagnostic biomarkers for early-stage CESC with LNM, and serve as prognostic predictors for patients with CESC.	Unknown